eDetailing & ROI
eDetailing: A Strategic Analysis of Implementation and ROI
The founder of interactive videoconferencing-style eDetailing speaks to us about developing the concept of eDetailing
eDetailing: Stimulating Food For Thought
Detailing is a long-standing way of Pharmaceutical companies telling Doctors about their drugs in a one-to-one sales call. Everyone in the Pharmaceutical industry knows the process.
Why pharmaceutical marketers must measure return on investment to ensure profitable eDetailing campaigns
Abstract All types of pharmaceutical marketing should be subject to careful analysis of costs and financial return. eDetailing, although a relatively new marketing method, must not be treated differently from any other off- or on-line marketing activity and the return on investment (ROI) of an eDetailing programme is essential to ensure success.
Navigating the eDetailing Maze
eDetailing is currently under consideration by many pharmaceutical companies as a way to maximise sales force time, cut costs and increase physician prescribing.
eDetailing in 2006 and Beyond
Colin Williams, e-Marketing Director at PharmiWeb Solutions takes a look at the current edetailing landscape and suggests what the future could hold for this much talked about tool for pharmaceutical sales and marketing departments.
Improving Sales Force Effectiveness with Digital Technology Part 1: e-Learning
Pharmaceutical companies depend on their sales force to build strong relationships with Physicians. However, a Forrester report stated that traditional detailing has ‘reached the end of its rope’.
Improving Sales Force Effectiveness with Digital Technology Part 2: eDetailing
Since the total US sales force of the top 40 pharmaceutical companies has approximately doubled in the last 5 years to around 63,000 (1999 figures), which is in stark contrast to the 15% growth in traditional detail visits, pharmaceutical companies are re-evaluating the effectiveness of the current traditional-only detailing practices.
'The
7 Secrets